JLPC: The newly built oral solution production line No. 1 has passed the drug GMP compliance inspection for the first time

JLPC announced that recently, its wholly-owned subsidiary JLPC received the "Drug GMP Compliance Inspection Notification" from the Anhui Provincial Drug Administration website. The inspection scope covers oral solution preparations, involving the production line 1 of the oral solution workshop, with the inspection scheduled from June 4 to June 7, 2025. This inspection is based on the drug GMP compliance inspection conducted for the entrusted production of Ebastine oral solution. As of the announcement date, the investment in the oral solution production line is approximately RMB 7.5 million